Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57BQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,352
Award facts
- Contract value 100% obligated
- $40,352.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,352.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml quantities. The contract, issued on January 2, 2026, with an ultimate completion date of January 5, 2026, represents a non-competitive, non-set-aside procurement. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated extensive capability in fulfilling DLA requirements across diverse therapeutic domains including diabetes medications, neurological treatments, pain management, antibiotics, and specialized medical supplies. The company's portfolio of federal contract awards reflects its role as a primary supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical IDC enables flexible procurement of brand-name and generic drugs, vaccines, and medical commodities to support worldwide military health operations, with the agency planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F57BQ?
SPE2DR26F57BQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F57BQ worth?
The government has obligated $40,352 on SPE2DR26F57BQ.
Is contract SPE2DR26F57BQ an order under another contract?
Yes. SPE2DR26F57BQ is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57BQ competed?
The extent of competition for SPE2DR26F57BQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award